Eric Newman

Q: What is Eric Newman email address?

Email Eric Newman at ejncpa52@yahoo.com and eric@hemanext.com. This email is the most updated Eric Newman's email found in 2026.

Q: How to contact Eric Newman?

To contact Eric Newman send an email to ejncpa52@yahoo.com or eric@hemanext.com.

Vice President and Chief Financial Officer at Hemanext | Hopedale, Massachusetts, United States

Profile last verified July 2026

Biotechnology Verified Profile Hopedale, Massachusetts, United States

Eric Newman’s Email & Phone Number

Verified

Work Email

***@hemanext.com

Last verified August 2026

Personal Email

***@yahoo.com

Personal • High Confidence

Phone Number

(413) ***-*333

United States • Phone

Free account · No credit card · 5 profiles/month

Eric Newman Work Experience

Vice President and Chief Financial Officer at Hemanext in January 2018 - Present

Corporate Officer and Director of Finance (TEI Biosciences and TEI Medical) at Integra LifeSciences (OTT Division - "TEI") - Integra Acquired TEI entities for $312M in January 2008 - January 2017

Director of Finance/Controller at PointCare Technologies in January 2003 - January 2008

See more See less

Controller/Director of Finance at Union Biometrica (Acquired by Harvard Bioscience in 2001) in January 2000 - January 2001

Eric Newman Skills

Working Capital Management Strategy Relationship Development Statutory Financial Controlling Construction Executive Management Business Metrics Working with Investors Tax Strategy Investor Presentations Investor Development Funding Analytical Skills Operational Efficiency Manufacturing Forward Planning Executive Leadership Cost Variance Analysis Manufacturing Accounting Financial Planning and Analysis (FP&A) Transformational Projects Business Reviews Financial Regulations Team Motivation Income Statements Risk Management Investment Strategies Angel Investing Financial Variance Analysis Financial Statement Auditing Corporate Venture Capital Board of Directors Financial Forecasting Early-Stage Startups Board of Directors Reporting Audit Committee PE Foreign Operations Operating Budgets Loan Covenants Term Sheets Key Performance Indicators Debt Financing Capital Structure Business Planning Vendor Relations Strategic Visionary Job Costing Board Relations Investor Relations Financing Financial Performance Capital Management QuickBooks Corporate Tax Strategy Implementation Certified Public Accounting Tax Accounting Tax Financial Planning Business Profitability Tax Preparation Cash Flow Financial Audits Mergers & Acquisitions (M&A) Account Management Business Strategy Financial Statements Generally Accepted Accounting Principles (GAAP) Account Reconciliation Accounts Receivable (AR) Accounts Payable (AP) Tax Planning Tax Compliance Regulatory Compliance Annual Budgeting Project Finance Covenant Compliance Construction Accounting Managerial Finance Cash Management Balance Sheets Strategic Financial Management New Business Development Accounting Forecasting Financial Analysis Strategic Planning Budgets Medical Devices Finance Venture Capital General Ledger Financial Reporting SEC filings Revenue Recognition Start-ups Auditing Internal Controls

About Eric Newman’s Current Company

Hemanext Discover more about Hemanext

Eric Newman’s Colleagues

Cheryl Mcleod

Peabody, Massachusetts, United States

Executive Assistant at Hemanext (Part-Time)

Executive Assistant at Hemanext
(October 2022 – Present)

Daan Kok

Zug, Zug, Switzerland

Pharma and MedTech Executive | FCMA, CGMA | Advisor & Investor in Healthcare

Head of BD and Strategy at Hemanext
(Oct 2024 – Present)

M Ray

Raleigh-Durham-Chapel Hill Area

Growth-Focused MedTech Executive | Driving U.S. & Global Commercialization

President and Chief Executive Officer at Hemanext
(Feb 2026 – Present)

Hayden Pietrowski

United States

Regional Product Specialist | Dedicated To Improving Transfusion Care

Regional Product Specialist at Hemanext
(Jan 2026 – Present)

Jay Jayasuriya

Rockville, Maryland, United States

Director, IT at Hemanext | IT Program Management Professional

Hemanext is developing a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle.

Myself involved in...